side effects of semaglutide long term kidney issues with Long-term outcomes in obesity and cardiovascular disease in the SELECT trial Semaglutide significantly reduces risk of – How Long Has Semaglutide Been

Yang HM (2025) Overcoming the bloodbrain barrier: advanced strategies in targeted drug delivery for neurodegenerative diseases

Before a new drug is approved for prescription use, the Food and Drug Administration (FDA) requires extensive The myth that GLP-1s cause stomach damage likely stems from the fact that the medication slows down the digestion of food, which can lead to common side effects, including nausea, diarrhea, and constipation

Stay active, as regular movement and exercise support gut motility

The 61-year-old company is initiating a business and brand transformation, rethinking its positioning in a weight loss market upended by the rise of GLP-1 anti-obesity drugs including Ozempic

Neuroinflammation and oxidative stress are key pathological features of PD [8, 9]